Related Experiment Video
Updated: Jan 8, 2026
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Exploring shared diagnostic genes and molecular mechanisms in multiple sclerosis and psoriasis through bioinformatics
Yuting Kong1, Xinmin Li2, Fangjie Yang1
1Rehabilitation Medicine College, Henan University of Chinese Medicine, Zhengzhou, Henan, 450000, China.
Background:
Multiple sclerosis (MS) and psoriasis are both immune-mediated inflammatory diseases. Previous studies have reported comorbidity between MS and psoriasis, but the underlying mechanisms remain unclear. This study aims to elucidate the shared pathogenesis and core genes underlying MS and psoriasis.
Methods:
Microarray data for MS and psoriasis were downloaded from the GEO database. Differentially expressed genes (DEGs) were analyzed using "limma" package. Functional enrichment analyses were conducted to elucidate biological functions of common DEGs. PPI analysis and machine learning were used to select core genes, and the diagnostic efficacy was evaluated using nomograms. Single-cell analysis and CeRNA network construction were performed. Immune cell infiltration was assessed by single-sample gene set enrichment. Drug prediction, molecular docking and molecular dynamics (MD) simulations identified potential therapeutic drugs.
Results:
89 DEGs identified in MS and psoriasis datasets were enriched in the NOD-like receptor, NF-κB, and JAK-STAT signaling pathways. IL7R and IRF8 were determined as core genes with good diagnostic performance (AUC >0.7). Immune infiltration analysis showed dysregulation of activated CD4 T cells, activated dendritic cells, and gamma delta T cells in both diseases. Single-cell analysis suggested that IL7R and IRF8 were mainly expressed in immune cells. Molecular docking and MD simulations revealed that parthenolide is a potential therapeutic agent.
Conclusion:
This study highlights the critical role of immune dysregulation and chronic inflammation in MS and psoriasis comorbidity. IL7R and IRF8 were identified as core genes and novel intervention targets for both diseases. These findings provide new insights for future research.
Insights
This study identifies IL7R and IRF8 as key genes in multiple sclerosis (MS) and psoriasis, revealing shared immune pathways. These findings offer potential new therapeutic targets for these immune-mediated diseases.
Area of Science:
- Immunology
- Genetics
- Computational Biology
Background:
- Multiple sclerosis (MS) and psoriasis are immune-mediated inflammatory diseases with unclear shared mechanisms.
- Previous research suggests a comorbidity between MS and psoriasis, necessitating investigation into their underlying pathogenesis.
Purpose of the Study:
- To elucidate the shared pathogenesis and identify core genes common to both MS and psoriasis.
- To explore potential therapeutic targets for these interconnected diseases.
Main Methods:
- Utilized microarray data from MS and psoriasis datasets, analyzing differentially expressed genes (DEGs) with the 'limma' package.
- Performed functional enrichment, protein-protein interaction (PPI) analysis, and machine learning to identify core genes.
- Conducted single-cell analysis, CeRNA network construction, immune cell infiltration assessment, and molecular simulations for drug prediction.
Main Results:
- Identified 89 common DEGs enriched in NOD-like receptor, NF-κB, and JAK-STAT signaling pathways.
- IL7R and IRF8 were identified as core genes with significant diagnostic potential (AUC > 0.7).
- Observed dysregulation in activated CD4 T cells, dendritic cells, and gamma delta T cells; parthenolide emerged as a potential therapeutic agent.
Conclusions:
- Immune dysregulation and chronic inflammation are critical in MS and psoriasis comorbidity.
- IL7R and IRF8 represent novel intervention targets for both MS and psoriasis.
- The study provides novel insights into the shared biology and potential treatments for these conditions.
